CSMD1 and cervical squamous intraepithelial neoplasia: Having fewer GS tumors in CSMD1-mut patients predicted better prognoses, while having fewer CIN tumors indicated that fewer people can benefit from adjuvant chemotherapy, but the significant increase in MIS among CSMD1-mut patients meant that these patients were more suitable for immunotherapy.